AJR ARRS PQI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pandit-Taskar, N.
Right arrow Articles by Yeung, H. W. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pandit-Taskar, N.
Right arrow Articles by Yeung, H. W. D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
AJR 2004; 183:1143-1147
© American Roentgen Ray Society


Nuclear Medicine

Clinical Significance of Unexplained Abnormal Focal FDG Uptake in the Abdomen During Whole-Body PET

Neeta Pandit-Taskar1, Heiko Schöder, Mithat Gonen, Steven M. Larson and Henry W. D. Yeung

1 All authors: Department of Radiology, Nuclear Medicine Service, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10021.

OBJECTIVE. FDG PET is frequently used as part of the diagnostic workup in cancer patients. Visualization of radiotracer-avid foci suggests the presence of malignant disease. Unexplained focal FDG accumulation in the abdomen is sometimes noted, but the clinical significance of this finding is unknown. Therefore, we followed cases with unexplained focal abdominal FDG uptake found incidentally on whole-body scans to define the cause and clinical significance of this finding.

CONCLUSION. Unexplained focal abdominal FDG uptake is an unusual finding with causes that include malignant and benign processes. Among the 14 cases with definitive diagnoses, seven were adenomas, which is a premalignant condition, and five (35.7%) were malignant. Therefore, although rare, unexplained focal abdominal FDG uptake should not be ignored and further diagnostic workup is warranted.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
JCOHome page
A. Yoshida, S. Borkar, B. Singh, R. A. Ghossein, and H. Schoder
Incidental Detection of Concurrent Extramedullary Plasmacytoma and Amyloidoma of the Nasopharynx on [18F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography
J. Clin. Oncol., December 10, 2008; 26(35): 5817 - 5819.
[Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
M. J. Gollub, T. Akhurst, A. J. Markowitz, M. R. Weiser, J. G. Guillem, L. McG. Smith, S. M. Larson, and A. R. Margulis
Combined CT Colonography and 18F-FDG PET of Colon Polyps: Potential Technique for Selective Detection of Cancer and Precancerous Lesions
Am. J. Roentgenol., January 1, 2007; 188(1): 130 - 138.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
H. Schoder and M. Gonen
Screening for Cancer with PET and PET/CT: Potential and Limitations
J. Nucl. Med., January 1, 2007; 48(1_suppl): 4S - 18S.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
H. B. Prabhakar, D. V. Sahani, A. J. Fischman, P. R. Mueller, and M. A. Blake
Bowel Hot Spots at PET-CT
RadioGraphics, January 1, 2007; 27(1): 145 - 159.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
G. J. Kelloff, J. M. Hoffman, B. Johnson, H. I. Scher, B. A. Siegel, E. Y. Cheng, B. D. Cheson, J. O'Shaughnessy, K. Z. Guyton, D. A. Mankoff, et al.
Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development
Clin. Cancer Res., April 15, 2005; 11(8): 2785 - 2808.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Roentgen Ray Society.